Comparative analysis of life quality parameters of patients with a combination of stable coronary artery disease and metabolic syndrome
Background and aims. In recent years, the problem of comorbid course srable coronary heart disease (SCAD) and metabolic syndrome (MS) has increased significantly due to their high medical and social significance, high costs for diagnosis and treatment, reduced quality of life (QOL). The aim of the study was to conduct a comparative analysis of QOL of patients with SCAD on the background of MS in comparison to a group of patients with isolated SCAD.
Material and methods. The study included 52 patients with MS in combination with SCAD and 50 patients with SCAD. QOL of all patients was assessed using the general medical questionnaire – the Medical Outcomes Study 36-Item (SF-36) of a specialized questionnaire for patients with stable angina pectoris SAQ (Seattle Angina Questionnaire).
Results. The study found a significantly lower level of QOL in patients with comorbid course of MS and SCAD in both psychological and physical components of health (by SF-36 questionnaire) compared with patients with SCAD (p<0.05). According to the SAQ questionnaire, it was proved that in patients with MS in combination with SCAD the QOL was statistically significantly lower on all scales relative to the group of patients with isolated SCAD (by 8.76 %) (p <0.05).